The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
CELL THERAPIES PTY LTD
Melbourne, Australia
A
11-50 Employees
2002
Key takeaway
Cell Therapies is a contract development and manufacturing organization (CDMO) with over 20 years of experience in GMP manufacturing of cell and gene therapies. They provide comprehensive services that ensure compliance with global regulatory standards, making them a key player in the development and commercialization of advanced gene therapies.
Reference
Core business
Cell Therapies | GMP Manufacturing of cell and gene therapies
Groundbreaking cell and gene therapy manufacturing and commercialization cell therapies is an Australian-based, globally-active commercial contract developm ...
EnGeneIC
Sydney, Australia
A
11-50 Employees
2000
Key takeaway
EnGeneIC is a clinical-stage biopharmaceutical company that develops its proprietary EDV™ nanocell platform, which enables the targeted delivery of chemotherapeutics and functional nucleic acids, potentially enhancing the effectiveness of cancer treatments while reducing toxicity. This innovative approach may have implications for in vivo gene therapy applications.
Reference
Product
Technology - EnGeneIC
TechnologyEnGeneIC is a clinical stage biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform that enables current cancer treatments to be more potent and far less toxic, while also stimulating a potent anti-tumor immune response.EDV … Continue reading →
TGR BioSciences
Adelaide, Australia
A
11-50 Employees
2001
Key takeaway
TGR BioSciences specializes in innovative solutions for cell-based research and offers advanced immunoassay technologies, including their patented CaptSure™ system. Their SureFire® Ultra and SureFire® Multiplex assays provide tools for analyzing proteins, which may be relevant for applications in gene therapy research.
Reference
Core business
TGR BioSciences
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Cartago Biotech Pty Ltd
Sydney, Australia
A
1-10 Employees
2020
Key takeaway
Cartago Biotech is focused on innovative approaches to tissue regeneration, which may have implications for enhancing the quality of life for patients with chronic back pain.
Reference
Product
Cartago Biotech Pty Ltd - Chronic Back Pain, Tissue Regeneration
Better quality of life
GeneType
Australia
A
51-100 Employees
1989
Key takeaway
The company, GeneType, is focused on developing advanced genetic testing and assessment tools that empower both physicians and patients to manage health proactively. Their innovative approach integrates predictive genetic testing with clinical risk models, enhancing personalized disease screening and prevention strategies.
Reference
Core business
About Us | GeneType | Genetic Technologies
Preserving and Promoting Healthy Futures. By combining genetic and clinical risk models with cutting-edge research, we're leading a personalized healthcare revo
Myrio Tx
Melbourne, Australia
A
11-50 Employees
2009
Key takeaway
Myrio Therapeutics is focused on developing antibody-based therapies that can target intracellular proteins, including those associated with cancer and viral infections. Their innovative Retained DisplayTM (ReD) technology enhances the discovery of these therapeutic antibodies.
Reference
Core business
Homepage - Myrio Tx
GeneWorks
Adelaide, Australia
A
- Employees
1996
Key takeaway
GeneWorks is an independent Australian company that specializes in the distribution of innovative instruments, kits, reagents, and software, highlighting their expertise and support in the life sciences sector. With a strong understanding of customer needs and the technology behind their products, they position themselves as a trusted partner in the field.
Reference
Core business
Geneworks
ImmVirX
Newcastle, Australia
A
11-50 Employees
2019
Key takeaway
ImmVirX is developing a new generation of cancer treatments through its innovative oncolytic immunotherapy that uses proprietary RNA viruses to selectively target and kill cancer cells while stimulating the immune response. Their approach aims to enhance the effectiveness of existing cancer immunotherapies, particularly for difficult-to-treat cancers.
Reference
Core business
ImmVirX - Receptor Targeted Oncolytic Viruses
ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
Novotech
Sydney, Australia
A
501-1000 Employees
1996
Key takeaway
The company, Novotech, specializes in providing high-quality clinical development services that could support advances in therapeutic products, including those related to in vivo gene therapy. They emphasize their expertise in regulatory affairs and pre-clinical support, which are crucial for the successful development of innovative treatments.
Reference
Service
GMO Solutions | Novotech CRO
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Reg
Invion
Melbourne, Australia
A
- Employees
-
Key takeaway
Invion is at the forefront of research and development, particularly with its Photosoft™ technology, which may have implications for innovative therapeutic approaches like in vivo gene therapy.
Reference
Core business
Discovery and Development Experts – Invion
Technologies which have been searched by others and may be interesting for you:
In Vivo Gene Therapy in Australia presents a dynamic landscape for exploration, marked by several key considerations. Regulatory frameworks are crucial; the Therapeutic Goods Administration (TGA) governs gene therapy products, ensuring safety and efficacy. Understanding these regulations is essential for compliance and successful market entry. Challenges include scientific complexities, such as delivery mechanisms and potential immune responses, which can impact treatment effectiveness. The competitive landscape features established players and emerging biotech firms, emphasizing the importance of innovation and collaboration in research and development. Opportunities abound in Australia due to its strong healthcare infrastructure and growing investment in biotechnology. Increased public and private funding supports advancements in gene therapies, particularly for genetic disorders and rare diseases. Moreover, the global market relevance of in vivo gene therapy is expanding, driven by advancements in technology and greater acceptance among healthcare providers. Environmental concerns, particularly related to bioethical implications and long-term effects, require ongoing assessment to ensure responsible practices. For those researching companies in this field, a comprehensive understanding of these factors will enable informed decisions and foster engagement in the evolving landscape of in vivo gene therapy in Australia.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | Australia |
| Amount of fitting manufacturers | 139 |
| Amount of suitable service providers | 87 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1989 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Other, Medical, Healthcare, Pharmaceuticals
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
